OMER Q4 2021 Earnings — Omeros Corporation Revenue & Financial Results | Market Cap Arena

OMEROmeros Corporation

$835M

Q4 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

-$80M-851.4% YoY

Gross Profit

-$79M98.8% margin

Operating Income

-$101M126.1% margin

Net Income

$281M-351.3% margin

EPS (Diluted)

$4.48

QoQ Revenue Growth

-Infinity%

Cash Flow

Operating Cash Flow

-$18M

Free Cash Flow

-$18M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$419M

Total Liabilities

$395M

Stockholders' Equity

$24M

Cash & Equivalents

$101M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	-$80M	$11M	-851.4%
Gross Profit	-$79M	$11M	-848.7%
Operating Income	-$101M	-$34M	-197.9%
Net Income	$281M	-$37M	+852.9%